Each CRS will complete the protocol registration process for all clinical research supported and/or sponsored by DAIDS that is reviewed by DAIDS Scientific Review Committees, namely the Prevention Sciences Review Committee (PSRC) and the Clinical Sciences Review Committee (CSRC), if it is determined that protocol registration is required. Upon receiving final IRB/EC and other applicable RE/Approving Entity approval(s), the CRS will submit all required registration documents to the DAIDS RSC PRO via the DPRS.
Protocol Registration at a Glance
March 2016
Creating a New Submission in the DPRS Quick Reference Card
Version 1.1 - April 2016
Protocol Registration Checklist
This document must be submitted with each submission made through the electronic protocol registration (EPR) mailbox to the DAIDS PRO.
Alternate format(s) available:
- Protocol Registration Checklist
April 2010
DAIDS RSC PRO Timelines
April 2010
Electronic Protocol Registration (EPR) Guidelines
April 2010
The EPR is an alternate way CRSs can submit registration materials via email to the DAIDS RSC PRO if they encounter problems when trying to submit registration materials through the DPRS.
DAIDS Clinical Trial Application Submission Checklist
Version 1.0 – November 2018
Resources
Enrolling Children in Clinical Research
Per the DAIDS Policy for Enrolling Children (including Adolescents) in NIAID (DAIDS)-supported and/or -sponsored Human Subject Clinical Research, for research studies including children or adolescents, DAIDS requires documentation of the IRB/EC designation of the pediatric risk or benefit category from the U.S. Federal regulations, 45 CFR 46.404-407 & 21 CFR 50.51-54 and IRB/EC approval for involvement of children based on the determination specified by that category.
DAIDS Policy for Enrolling Children in Research
October 2022
45 CFR Part 46 - Protection of Human Subjects
July 2009
21 CFR Part 50 - Protection of Human Subjects
April 2015
IBC Oversight of Research with Recombinant DNA
NIH Office of Science Policy
Biosafety and Recombinant DNA Policy